Showing 1 - 2 results of 2 for search 'Accountancy', query time: 0.33s Refine Results
  1. 1
    Sorafenib is the first targeted agent to treat metastatic kidney cancer
    by V. B. Matveev, V. A. Chernyaev
    Published 2015-03-01
    “... because of intolerability of the drug is not greater than 10 %. Thus, by taking into account...”
    Get full text
    Article
  2. 2
    Sorafenib is the first targeted agent to treat metastatic kidney cancer
    by V. B. Matveev, V. A. Chernyaev
    Published 2015-03-01
    “... of intolerability of the drug is not greater than 10 %. Thus, by taking into account of the possible sequence...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search